Dementia & Psychotropic Medications: Microlearning for Aged Care Staff
A new series of short, practical videos has been launched to help clinicians and aged care workers use psychotropic medications more safely for people living with dementia in residential care settings. Developed jointly by researchers at Monash University and Flinders University, the microlearning modules aim to improve the appropriate use of these drugs, addressing a critical need in aged care where psychotropic medications are often prescribed – and sometimes inappropriately so – to manage behavioral and psychological symptoms of dementia.
Understanding the Challenge: Psychotropic Medications in Aged Care
Psychotropic medications – a category that includes antipsychotics, antidepressants, and benzodiazepines – can be valuable tools in managing certain conditions. However, their use in older adults, particularly those with dementia, carries significant risks. These risks include increased falls, stroke, and even mortality. The microlearning series is directly informed by the Clinical Practice Guidelines for the Appropriate Use of Psychotropic Medications in People Living with Dementia and in Residential Aged Care, aiming to translate those recommendations into everyday practice.
The new resource comes at a time when attention to medication safety in aged care is particularly high. Concerns about over-prescription and the potential for harm have prompted increased scrutiny and a push for more evidence-based approaches to care. The videos are designed to address this need by providing accessible, focused education for busy healthcare professionals.
What the Microlearning Series Offers
The series consists of 12 modules, each approximately five to seven minutes in length. This “microlearning” format is based on educational psychology research suggesting that shorter, focused learning units are more effective for knowledge retention and application. The modules cover key aspects of psychotropic medication management, including:
- Initiation of antipsychotics, antidepressants, and benzodiazepines
- Monitoring patients for side effects and effectiveness
- Safe discontinuation of these medications
Researchers from The Centre for Medicine Use and Safety (CMUS) within the Monash Institute of Pharmaceutical Sciences (MIPS) and the Caring Futures Institute at Flinders University collaborated on the project. Professor Simon Bell, Director of CMUS, emphasized that the videos are intended to support consistent and confident application of the clinical practice guidelines in daily practice. The videos are not a standalone resource; they complement a broader suite of materials, including a companion guide available in six languages, nine one-page medication factsheets, and a curated inventory of existing Quality Use of Medicines (QUM) resources.
The Importance of Targeted Education
Dr. Michael Lawless, from the College of Nursing and Health Sciences at Flinders University, highlighted the rationale behind the microlearning approach. He explained that this method aligns with how the human brain best encodes, stores, and retrieves information. Traditional, lengthy training sessions can be overwhelming and less effective than delivering information in smaller, more manageable chunks over time. This is particularly relevant for healthcare workers who are often juggling multiple responsibilities and facing time constraints.
Beyond the Videos: A Comprehensive Resource Suite
The microlearning videos are part of a larger effort to improve the quality of care for people living with dementia. The accompanying resources – the multilingual companion guide and medication factsheets – provide additional support for clinicians and caregivers. The curated inventory of QUM resources offers access to a wider range of evidence-based tools and information. This comprehensive approach recognizes that effective medication management requires ongoing education, access to relevant information, and a commitment to best practices.
What Does This Indicate for Residents and Families?
The ultimate goal of this initiative is to improve the quality of life for people living with dementia in residential aged care. By promoting the safer and more appropriate use of psychotropic medications, the researchers hope to reduce the risk of adverse effects and enhance the overall well-being of residents. This includes minimizing unnecessary medication use, carefully monitoring those who are prescribed these drugs, and ensuring that treatment decisions are aligned with individual needs and preferences.
Families also play a crucial role in medication management. Open communication with healthcare providers is essential to ensure that they understand the rationale for any medications prescribed and are aware of potential side effects. The availability of resources in multiple languages can help to facilitate this communication and empower families to advocate for their loved ones.
Looking Ahead: Ongoing Evaluation and Refinement
The launch of the microlearning video series is not the complete of the process, but rather a significant step forward. Researchers will continue to evaluate the effectiveness of the videos and other resources, gathering feedback from clinicians and caregivers to identify areas for improvement. The Evidence-based Medication knowledge Brokers in Residential Aged CarE (EMBRACE) trial, which informed the development of the series, will continue to provide valuable insights into the challenges and opportunities for improving medication safety in aged care. Mirage News reports that this is an ongoing effort to refine best practices.
Further research is needed to explore the long-term impact of these interventions on patient outcomes and to identify innovative strategies for promoting medication safety in aged care settings. The ongoing commitment to education, research, and collaboration will be essential to ensure that people living with dementia receive the highest quality of care.
For more information on appropriate psychotropic medication use, consult with a qualified healthcare professional or refer to official guidance from organizations such as the National Prescribing Service (NPS) Australia.